Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

EGM Statement

30 Jun 2008 12:12

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008

VERNALIS PLC

RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2. To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3. To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes

Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.

Document Viewing Facility

The Financial Services Authority

25 The North ColonadeCanary Wharf

London E14 5HS

Tel: 020 7066 1000

Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ
Date   Source Headline
27th Sep 20137:00 amRNSAppointment of Nominated Advisor and Broker
26th Sep 201311:52 amRNSHolding(s) in Company
12th Sep 20135:41 pmRNSHolding(s) in Company
29th Jul 20134:00 pmRNSHolding(s) in Company
29th Jul 20137:00 amRNSInterim results for six months ended 30 June 2013
26th Jul 20135:45 pmRNSHolding(s) in Company
26th Jul 20135:10 pmRNSHolding(s) in Company
26th Jul 20134:48 pmRNSHolding(s) in Company
12th Jul 20137:00 amRNSVernalis Initiates Phase Ib/II POC Study of V81444
11th Jul 20137:00 amRNSNotice of Results for 6 months ended 30 June 2013
8th Jul 20133:17 pmRNSHolding(s) in Company
13th Jun 20137:00 amRNSFrovatriptan data to be presented at IHC
22nd May 201311:43 amRNSResult of AGM
29th Apr 20135:10 pmRNSHolding(s) in Company
26th Apr 201311:29 amRNSTransaction of Directors
19th Apr 201312:00 pmRNSTransaction by Directors
17th Apr 20139:22 amRNSNotice of Annual Report and AGM
16th Apr 201312:24 pmRNSTransactions of Directors/Applicable Employees
10th Apr 20137:00 amRNSAnnouncement of Results for year ended 31/12/12
21st Mar 20137:00 amRNSNotice of Results
19th Mar 20135:34 pmRNSHolding(s) in Company
6th Mar 20137:15 amRNSVernalis and Servier Extend Oncology Collaboration
6th Mar 20137:00 amRNSFirst Product in Cough Cold Pipeline Achieves POC
4th Mar 20137:00 amRNSVernalis received a further $2.5m from Genentech
8th Feb 20134:10 pmRNSHolding(s) in Company
4th Feb 20137:00 amRNSVernalis receives $1.5 m milestone from Genentech
7th Jan 20137:00 amRNSVernalis and Servier Achieve Research Milestone
2nd Jan 20138:36 amRNSVernalis and Lundbeck Achieve Third Milestone
12th Dec 20127:00 amRNSPositive Results Achieved in RO Study of V81444
20th Sep 20127:00 amRNSVernalis & Servier Achieve Research Milestone
4th Sep 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20127:00 amRNSVernalis Initiates V81444 Receptor Occupancy Study
13th Aug 20127:00 amRNSVernalis to present at 14th World Congress on Pain
10th Aug 20122:56 pmRNSHolding(s) in Company
1st Aug 20127:00 amRNSInterim Results for six months ended 30 June 2012
10th Jul 201210:00 amRNSNotice of Results
1st Jun 201210:00 amRNSAUY922 Abstracts Accepted for Presentation at ASCO
30th May 20127:46 amRNSDirector/Applicable Employee Shareholding
22nd May 201212:50 pmRNSResult of AGM
2nd May 20127:00 amRNSSuccessful Outcome for V81444 in Phase I Study
27th Apr 20128:00 amRNSCancellation Vernalis Plc
27th Apr 20127:00 amRNSADMISSION OF SHARES TO AIM
26th Apr 20125:38 pmRNSChange of Registered Office
25th Apr 20127:00 amRNSVernalis and Servier Achieve Research Milestone
18th Apr 20125:05 pmRNSNotice of Annual Report and Annual General Meeting
3rd Apr 20127:00 amRNSAnnouncement of Results year ended 31 Dec 2011
27th Mar 20127:00 amRNSSchedule 1 - Vernalis plc
27th Mar 20127:00 amRNSCancellation of Listing/Proposed Admission to AIM
14th Mar 20127:00 amRNSNotice of Results
9th Mar 20125:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.